Special section on survival finds significant improvement for all but two cancer sites. Bethesda, Maryland–(ENEWSPF)–March 31, 2017. Overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups, according to the latest Annual Report to the Nation on the Status of Cancer,[Read More…]
Science
DEA To Classify Liquid, Synthetic THC As A Schedule II Controlled Substance
Washington, DC–(ENEWSPF)–March 30, 2017. Officials from the US Drug Enforcement Administration (DEA) have recommended that Syndros, a liquid form of synthetic THC, be classified as a Schedule II controlled substance under federal law. Food and Drug Administration (FDA) officials determined last year that the drug formulation is safe and effective[Read More…]
Multistate Outbreak of Shiga Toxin-producing E. coli Infections Linked to I.M. Healthy Brand SoyNut Butter
Atlanta, GA–(ENEWSPF)–March 30. 2017 What’s New Six more sick people have been reported since the last update on March 21, 2017. The most recent illness started on March 13, 2017. Two more people were hospitalized with hemolytic uremic syndrome (HUS), a type of kidney failure. The total is 29 sick[Read More…]
FDA URGENT NEWS: Envy Me Is Recalling LaBri’s Body Health Atomic 60 Capsules Due To Undeclared Sibutramine
Silver Spring, Maryland–(ENEWSPF)–March 30, 2017. Envy Me is recalling LaBri’s Body Health Atomic, dietary supplement marketed for weight loss, sold in 60 capsule, plastic bottles. The recall includes all lot codes, manufacturing codes and expiration dates. The United States Food and Drug Administration has analyzed samples of La Bri’s Body[Read More…]
FDA Approves New Drug to Treat Multiple Sclerosis
First drug approved for Primary Progressive MS Silver Spring, Maryland–(ENEWSPF)–March 30, 2017. On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by the FDA[Read More…]
Western Environmental Law Center: White House Rejects Scientific Consensus, Guts U.S. Climate Policy
Taos, New Mexico–(ENEWSPF)–March 28, 2017. In an executive order released by the White House today, President Trump seeks to reverse the core policy safeguards put in place by the Obama Administration to address climate change. The Trump order represents a sweeping attack on action to account for intensifying and anticipated[Read More…]
Use Your Zip Code to Attract Brilliant Birds to Your Yard This Spring
Audubon’s Native Plant Database Makes Ecologically Friendly Landscaping Choices a Snap Audubon’s Native Plant Database Makes Ecologically Friendly Landscaping Choices a Snap NEW YORK — (ENEWSPF)-March 28, 2017. With spring arriving earlier than usual and bird migration currently underway, the National Audubon Society invites nature enthusiasts to grow bird-friendly[Read More…]
FDA Approves New Eczema Drug Dupixent
Silver Spring, Maryland–(ENEWSPF)–March 28, 2017. The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable. Dupixent can be[Read More…]
FDA Approves Maintenance Treatment for Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancers
Silver Spring, Maryland–(ENEWSPF)–March 27, 2017. The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in[Read More…]
World Meteorological Organization Retires Storm Names Matthew and Otto
Category 4 Hurricane Matthew (Source: NOAA.gov) Hurricanes wreaked havoc through the Caribbean in 2016 Washington, DC–(ENEWSPF)–March 27, 2017. You’ve heard the last of Matthew and Otto – at least as Atlantic storm names. These two storms ravaged the Caribbean so much last year their names have been retired by the[Read More…]
